Metraipolis › archive › dc_5f55fedec475

First In Vitro Characterization of Salinomycinic Acid-Containing Two-Line Ferrihydrite Composites with Pronounced Antitumor Activity as MRI Contrast Agents — Europe PMC PMID:40943324

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40943324
DOI
10.3390/ijms26178405
License (as archived)
solo-consultazione
Archived
2026-11-10T06:23:35.166Z
SHA-256 of the archived text
00019f5d5f6f5491233a95acebbfacfda04f57aa41a82f02723f70bc4a4360c4
Stable URL of this page
https://metraipolis.com/documento/dc_5f55fedec475

How to cite

First In Vitro Characterization of Salinomycinic Acid-Containing Two-Line Ferrihydrite Composites with Pronounced Antitumor Activity as MRI Contrast Agents — Europe PMC PMID:40943324 — Europe PMC (en), https://europepmc.org/article/MED/40943324 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5f55fedec475 (Metraipolis archive dc_5f55fedec475, sha256 00019f5d5f6f5491233a95acebbfacfda04f57aa41a82f02723f70bc4a4360c4)
BibTeX
@misc{dc5f55fedec475,
  title = {First In Vitro Characterization of Salinomycinic Acid-Containing Two-Line Ferrihydrite Composites with Pronounced Antitumor Activity as MRI Contrast Agents — Europe PMC PMID:40943324},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40943324},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5f55fedec475; sha256 00019f5d5f6f5491233a95acebbfacfda04f57aa41a82f02723f70bc4a4360c4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40943324. Agents can read the archived copy with the MCP tool read_document.